Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) in Adolescents: Practical Guidance and Management Challenges.
Rowe, Katherine · Adolescent health, medicine and therapeutics · 2023 · DOI
Quick Summary
ME/CFS is a serious illness causing extreme tiredness that doesn't improve with rest, along with worsening after activity, brain fog, poor sleep, and sometimes dizziness and pain. This paper reviews what we know about treating ME/CFS in teenagers and young people, finding that currently there are no proven cure treatments, but symptom management and lifestyle adjustments help most. The study emphasizes that staying connected to school and having supportive doctors who listen made the biggest difference in how well young people managed their illness over time.
Why It Matters
This paper directly addresses adolescents with ME/CFS, a vulnerable population facing decades of potential illness during critical developmental years. It provides practical, evidence-based guidance that incorporates patient perspectives and emphasizes the importance of holistic management beyond physical symptoms, which can improve clinical care and outcomes.
Observed Findings
- Mean illness duration in adolescents is approximately 5 years, with range of 1-16 years
- Approximately 20% of patients have significant functional restrictions persisting after 10 years of illness
- Young people identified symptom management, self-management strategies, advocacy, and educational liaison as most helpful
- Patients valued clinicians who listened seriously and provided explanation and support after excluding alternative diagnoses
- Remaining engaged in education was the strongest predictor of better long-term functioning
Inferred Conclusions
- Graded exercise therapy and cognitive behavior therapy are no longer recommended as primary treatments; symptom management and lifestyle support are the current standard approach
- ME/CFS appears to be a multisystem neuroimmune disorder, evidenced by renewed research interest following Long COVID observations
- Holistic developmental support addressing social, emotional, cognitive, and educational impacts is as critical as managing physical symptoms in adolescent patients
- Therapeutic alliance and patient-centered care significantly influence illness trajectory and patient satisfaction
Remaining Questions
- What are the specific biological mechanisms underlying ME/CFS's multisystem neuroimmune dysfunction?
- Which symptom management strategies are most effective for specific symptom clusters, and can they be personalized?
- What interventions prevent or reduce the 20% of adolescents who develop significant long-term functional restrictions?
- How can educational continuity be optimally supported while accommodating fluctuating disease severity?
What This Study Does Not Prove
This review does not establish definitive causes of ME/CFS or prove efficacy of any specific treatment through controlled trials. The patient feedback, while valuable, represents qualitative observations rather than rigorous outcome measures, and recommendations reflect consensus rather than level-1 evidence.
Topics
Tags
Metadata
- DOI
- 10.2147/AHMT.S317314
- PMID
- 36632532
- Review status
- Editor reviewed
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 7 April 2026